Title: The Newborn Metabolic Screening Market To Take A Parabolic Turn With A CAGR Of 9.2%
1Newborn Metabolic Screening Market
Report Id PMRREP31998 Category Life Science
Healthcare
2About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
- Customized Research
- Syndicated Research
- Investment Research
- Social Media Research
- Automotive and Transportation
- Electronics, Semiconductor, and ICT
- Retail and Consumer Products
- Industrial Automation and Equipment
- Chemicals Materials
- Food and Beverages
- Services and Utilities
- Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3How Would Global Contribute To The Growth Of The
Newborn Metabolic Screening Market?
- Increasing birth rates across the world are
expected to drive demand for newborn metabolic
screening, as the risk of galactosemia, sickle
cell disease, phenylketonuria, maple syrup urine
disease, and cystic fibrosis is higher among
infants. Various countries are implementing
screening for metabolic diseases in newborns as a
part of their immunization programs. To remain
competitive and ensure a robust product pipeline,
leading companies continue to identify potential
assets through pilot screening programs, which
typically have limited resources to see projects
through the market. - According to a latest report published by
Persistence Market Research, the global newborn
metabolic screening market was valued around US
247 Mn in 2020, and is expected to witness an
impressive CAGR of over 9 during the forecast
period (2020 2030).
Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/31998
4Key Takeaways from Market Study
- Sickle cell disease is expected to contribute
more than 30 of revenue share to the market. - By sample, blood testing held the highest market
share in 2019 due to efficient diagnostic
results. - Europe holds a significant share of over 30 in
the global newborn metabolic screening market. - Leading manufacturers are focused on
strengthening their product portfolios and
regional expansion through collaborations. - Hospitals are expected to hold significant market
share, due to high number of screening programs
being arranged in collaboration with hospitals. - The COVID-19 outbreak has had a negative impact
on the market, as short-term lockdowns disturbed
the production and supply chain of kits. - The market in the U.S is projected to expand at a
CAGR of close to 10 through 2030. - The U.K market has a share of more than 17 in
Europe, and is expected to progress at a CAGR of
more than 12 over the next ten years. - Increasing prevalence of new born metabolic
diseases and rising adoption of related screening
program will boost the global market, says an
analyst of Persistence Market Research.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/31998
5(No Transcript)